SANDRA KEMPTNER: Open Payments
NPI 1265710396 · SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,970 in 123 payments from 21 companies in 2025. Trend: 2023 $3,650 · 2024 $2,994 · 2025 $2,970
Food & beverage: $2,870Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 30 | $597 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 11 | $308 |
| UCB, Inc. | 10 | $290 |
| ABBVIE INC. | 14 | $219 |
| GENZYME CORPORATION | 7 | $216 |
| PFIZER INC. | 11 | $202 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 5 | $199 |
| Arcutis Biotherapeutics, Inc. | 6 | $174 |
| E.R. Squibb & Sons, L.L.C. | 3 | $157 |
| Lilly USA, LLC | 6 | $146 |
Products named: TREMFYA, Bimzelx, DUPIXENT, Winlevi, SKYRIZI, Zoryve, CIBINQO, Sotyktu.
Industry payments across CA — which companies pay providers there.
